Construction of Dry Eye Artificial Intelligence Diagnosis System by Convolutional Neural Network

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100052575

Enrollment

Unknown

Registered

2021-10-31

Start date

2021-11-01

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry eye

Interventions

case group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: The patients with dry eye aged from 18 to 75 years.

Exclusion criteria

Exclusion criteria: 1. Patients with psychosis, cognitive dysfunction, cardiovascular and cerebrovascular accidents, malignant arrhythmia, and vital organ dysfunction. Systemic connective tissue diseases and severe autoimmune diseases, such as rheumatoid arthritis, sarcoidosis, lupus erythematosus, thyroiditis, etc; 2. Those who need to use eye drops for a long time with a history of eye surgery, a history of trauma or other diseases.

Design outcomes

Primary

Measure	Time frame
ocular surface disease index;symptom score;tear meniscus height;tear film break-up time;corneal fluorescein staining;lid margin score;	—

Countries

China

Contacts

Public ContactDai Qi

Eye Hospital and School of Ophthalmology and Optometry Wenzhou Medical University

dq@mail.eye.ac.cn+86 18667127070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026